| scholarly article | Q13442814 |
| P2093 | author name string | Jun Xu | |
| Rong Wang | |||
| Jinbao Guo | |||
| Zhenbing Lv | |||
| Jinlai Wei | |||
| Linglong Peng | |||
| Shouru Zhang | |||
| Wenxian You | |||
| Xingye Wu | |||
| Yongfu Xiong | |||
| Zhongxue Fu | |||
| P2860 | cites work | Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis | Q24607308 |
| Comprehensive molecular characterization of human colon and rectal cancer | Q24630415 | ||
| Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans | Q27860584 | ||
| Predictive biomarkers along gastric cancer pathogenetic pathways | Q39170872 | ||
| Effect of Cruciferous Vegetable Intake on Oxidative Stress Biomarkers: Differences by Breast Cancer Status | Q40302664 | ||
| Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue. | Q44001167 | ||
| Prediction of prognosis is not improved by the seventh and latest edition of the TNM classification for colorectal cancer in a single-center collective | Q44296108 | ||
| Novel blood-based, five-gene biomarker set for the detection of colorectal cancer | Q46802106 | ||
| ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients. | Q50784314 | ||
| Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. | Q51856604 | ||
| Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer. | Q53054042 | ||
| Has the new TNM classification for colorectal cancer improved care? | Q53143615 | ||
| The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. | Q54242652 | ||
| Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. | Q54590406 | ||
| Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer | Q56601042 | ||
| MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer | Q73743021 | ||
| Network biology: understanding the cell's functional organization | Q27861027 | ||
| Proteogenomic characterization of human colon and rectal cancer | Q28244320 | ||
| Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value | Q28488319 | ||
| Cancer statistics, 2016 | Q29547383 | ||
| MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer | Q29616316 | ||
| TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer | Q30488162 | ||
| A long non-coding RNA signature to improve prognosis prediction of colorectal cancer | Q33688589 | ||
| Current status of long non-coding RNAs in human cancer with specific focus on colorectal cancer | Q34158506 | ||
| Biomarkers for Colorectal Cancer | Q34205596 | ||
| Equivalence of MammaPrint array types in clinical trials and diagnostics | Q34519347 | ||
| Coming of age: ten years of next-generation sequencing technologies | Q34526801 | ||
| Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors | Q34624887 | ||
| Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. | Q34976152 | ||
| An integrated mRNA and microRNA expression signature for glioblastoma multiforme prognosis | Q35175490 | ||
| miR-23a, a critical regulator of "migR"ation and metastasis in colorectal cancer | Q36034372 | ||
| The degree of extramural spread of T3 rectal cancer: a plea to the UICC and AJCC. | Q36078310 | ||
| The degree of extramural spread of T3 rectal cancer: an appeal to the American Joint Committee on Cancer | Q36203331 | ||
| The consensus molecular subtypes of colorectal cancer | Q36258187 | ||
| Identification of endometrial cancer methylation features using combined methylation analysis methods | Q36302529 | ||
| The hallmarks of cancer: a long non-coding RNA point of view. | Q36391951 | ||
| miR-23a promotes the transition from indolent to invasive colorectal cancer | Q36837231 | ||
| Tumor deposits counted as positive lymph nodes in TNM staging for advanced colorectal cancer: a retrospective multicenter study | Q37109733 | ||
| Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients | Q37159825 | ||
| A long non-coding RNA signature to improve prognosis prediction of gastric cancer | Q37268013 | ||
| Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma | Q37301923 | ||
| MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients | Q37542251 | ||
| Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer | Q37636634 | ||
| Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers | Q37665607 | ||
| Protein-protein interaction networks and subnetworks in the biology of disease | Q37791993 | ||
| Long non-coding RNAs: a new frontier in the study of human diseases | Q38116266 | ||
| MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment | Q38147153 | ||
| The development and application of high throughput cultivation technology in bioprocess development. | Q38201927 | ||
| Population-based screening in colorectal cancer - current practice and future developments: faecal biomarkers review. | Q38221891 | ||
| The application of the high throughput sequencing technology in the transposable elements | Q38591817 | ||
| Large-scale analysis of microRNA expression, epi-transcriptomic features and biogenesis | Q38970745 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| edgeR | Q113334690 | ||
| P433 | issue | 49 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| microRNA | Q310899 | ||
| P304 | page(s) | 85463-85478 | |
| P577 | publication date | 2017-08-07 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | An integrated lncRNA, microRNA and mRNA signature to improve prognosis prediction of colorectal cancer | |
| P478 | volume | 8 |
| Q57484422 | A novel gene-pair signature for relapse-free survival prediction in colon cancer |
| Q92361660 | Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer |
| Q92557099 | Integrative analysis of miRNA and mRNA expression profiles reveals a novel mRNA/miRNA signature to improve risk classification for patients with gastric cancer |
| Q89966774 | Long non-coding RNA polymorphisms on 8q24 are associated with the prognosis of gastric cancer in a Chinese population |
| Q64279937 | Long noncoding RNAs predict the survival of patients with colorectal cancer as revealed by constructing an endogenous RNA network using bioinformation analysis |
| Q90429127 | MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside |
| Q58714868 | Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data |
| Q64063399 | Prognosis Prediction of Colorectal Cancer Using Gene Expression Profiles |
| Q91772657 | Prognostic implications of autophagy-associated gene signatures in non-small cell lung cancer |
| Q99581578 | Prognostic implications of metabolism-associated gene signatures in colorectal cancer |
| Q90151947 | Recurrence-Associated Multi-RNA Signature to Predict Disease-Free Survival for Ovarian Cancer Patients |
| Q97644783 | Weighed Gene Coexpression Network Analysis Screens the Potential Long Noncoding RNAs and Genes Associated with Progression of Coronary Artery Disease |
| Q47752840 | miR-202 inhibits cell proliferation, migration, and invasion by targeting EGFR in human bladder cancer |
Search more.